🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this expanded access program is to evaluate safety a...
Status
Approved For Marketing
Location
UCLA Hematology Oncology
Start Date
TBD
Trial ID
NCT04136808
Treatments Being Tested
The purpose of this study was to compare the overall survival (OS) of parti...
Status
Completed
Location
UCI Chao Family Comprehensive Cancer Center
Start Date
2018-06-27
Trial ID
NCT03474107
Treatments Being Tested
This study is testing a drug called enfortumab vedotin in up to 12 patients...
Status
Recruiting
Location
Froedtert Memorial Lutheran Hospital
Start Date
2026-07-10
Trial ID
NCT07139977
Treatments Being Tested
This is a Phase 2 clinical intervention trial to assess efficacy of inducti...
Status
Not Yet Recruiting
Location
Antoni van Leeuwenhoek ziekenhuis
Start Date
2026-09-01
Trial ID
NCT07663747
Treatments Being Tested
The ARON-2PLUS Study is designed as an International Multicentric Retrospec...
Status
Not Yet Recruiting
Location
Ospedale di Macerata
Start Date
2026-02
Trial ID
NCT07420855
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2018-09-11
Trial ID
NCT03606174
Treatments Being Tested
This is a non-randomized two arm open-label phase 2 pilot study in adult su...
Status
Active Not Recruiting
Location
Fox Chase Cancer Center - Philadelphia
Start Date
2023-06-14
Trial ID
NCT05923190
Treatments Being Tested
The goal of this study is to evaluate the feasibility and preliminary effic...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2026-08
Trial ID
NCT07548476
Treatments Being Tested
The purpose of this study was to determine the antitumor activity of enfort...
Status
Completed
Location
Site CN86001
Start Date
2021-07-22
Trial ID
NCT04995419
Treatments Being Tested
This is a study that will test how an experimental drug (enfortumab vedotin...
Status
Completed
Location
Alaska Urological Institute
Start Date
2017-10-08
Trial ID
NCT03219333
Treatments Being Tested